Medicon valley in 2016
Medicon Valley is a leading bi-national life-sciences cluster in Europe, spanning the Øresund Region of eastern Denmark and southern Sweden. It is one of Europe's strongest life science clusters, with a large number of life science companies and research institutions located within a relatively small geographical area. The name has officially been in use since 1997.
Contents
- Medicon valley in 2016
- Medicon valley www mva org medicon valley alliance
- Background and activities
- Science parks
- References
Major life science sectors of the Medicon Valley cluster includes pharmacology, biotechnology and medical technology. It is specifically known for its research strengths in the areas of neurological disorders, inflammatory diseases, cancer and diabetes.
Medicon valley www mva org medicon valley alliance
Background and activities
The cross-border region of Medicon Valley has a population of approximately 3.5 million inhabitants. In 2008, 60% of Scandinavian pharmaceutical companies were located in the region. The area includes 12 universities, 32 hospitals, and more than 300 life science companies. 20 are large pharmaceutical or medical technology firms and 170 are dedicated biotechnology firms. Between 1998 and 2008, 100 new biotechnology and medical technology companies were created here. The biotechnology industry alone employs around 40,000 people in the region, 4,000 of whom are academic researchers. International companies with major research centres in the region include Novo Nordisk, Lundbeck, LEO Pharma, and Ferring Pharmaceuticals. There are seven science parks in the region, all with a significant focus on life science, including the Medicon Village in Lund, established in 2010. Medicon Valley accounts for more than 20% of the total GDP of Denmark and Sweden combined.
The research and business of Medicon Valley is officially represented by the organisations Medicon Valley and Medicon Valley Alliance (MVA), connecting academia, hospitals and companies in the Øresund Region, comprising the Capital Region and Region Zealand in Denmark and Skåne in Sweden. The organisations were initiated by local industry in 1997, which already formed a strong knowledge base with five big pharmaceutical companies, the brewery Carlsberg and the University of Copenhagen in Denmark and Lund University in Sweden. Medicon Valley is promoted by Region Skåne and Copenhagen Capacity. Many of the region's universities has a strong heritage in biological and medical research and have produced several Nobel Prize winners. The almost century-long presence of a number of research-intensive and fully integrated pharmaceutical companies, such as Novo Nordisk, H. Lundbeck, AstraZeneca and LEO Pharma, has also contributed significantly to the medical research and business development of the region by strengthening abilities within applied research, attracting suppliers and producing spin-offs. The Øresund bridge that opened in 2000, makes commuting and transport across the Øresund strait easy, and it has been a major reason for the succes of the cluster.
In 2011, the organisations of MVA and Invest in Skåne, launched the concept of Beacons. Beacons are projects for creating world-leading cross-disciplinary research environments with a focus on areas where there are considerable potential for synergies in Medicon Valley specifically. After a long thorough selection process, the four Beacons of systems biology, structural biology, immune regulation and drug delivery were approved.
The Medicon Valley organisation issues the quaternal life science magazine "Medicon Valley".
Science parks
Science parks in Medicon Valley includes:
